IMPACT OF METHOTREXATE ON DISEASE PATTERN IN ACTIVE PSORIATIC ARTHRITIS PATIENTS ELIGIBLE FOR A RANDOMIZED CLINICAL TRIAL WITH USTEKINUMAB: COMPARATIVE BASELINE DATA FROM MULTICENTRE INVESTIGATOR-INITIATED MUST TRIAL

Rossmanith T, Koehm M, Kiltz U, Rech J, Burmester GR, Kellner H, Bulczak-Schadendorf A, Foldenauer AC, Burkhardt H, Behrens F (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 773-773

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

Event location: , ELECTR NETWORK

DOI: 10.1136/annrheumdis-2020-eular.5511

Authors with CRIS profile

Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology

Involved external institutions

Fraunhofer-Institut für Translationale Medizin und Pharmakologie (ITMP) / Fraunhofer Institute for Translational Medicine and Pharmacology DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE) Rheumazentrum Ruhrgebiet DE Germany (DE)

How to cite

APA:

Rossmanith, T., Koehm, M., Kiltz, U., Rech, J., Burmester, G.R., Kellner, H.,... Behrens, F. (2020). IMPACT OF METHOTREXATE ON DISEASE PATTERN IN ACTIVE PSORIATIC ARTHRITIS PATIENTS ELIGIBLE FOR A RANDOMIZED CLINICAL TRIAL WITH USTEKINUMAB: COMPARATIVE BASELINE DATA FROM MULTICENTRE INVESTIGATOR-INITIATED MUST TRIAL. In ANNALS OF THE RHEUMATIC DISEASES (pp. 773-773). , ELECTR NETWORK: LONDON: BMJ PUBLISHING GROUP.

MLA:

Rossmanith, T., et al. "IMPACT OF METHOTREXATE ON DISEASE PATTERN IN ACTIVE PSORIATIC ARTHRITIS PATIENTS ELIGIBLE FOR A RANDOMIZED CLINICAL TRIAL WITH USTEKINUMAB: COMPARATIVE BASELINE DATA FROM MULTICENTRE INVESTIGATOR-INITIATED MUST TRIAL." Proceedings of the Annual European Congress of Rheumatology (EULAR), , ELECTR NETWORK LONDON: BMJ PUBLISHING GROUP, 2020. 773-773.

BibTeX: Download